IVIM Health vs NovoCare Pharmacy (Wegovy) (2026): prices, structure, verdict

On tirzepatide, only IVIM Health↗ has a rankable figure: $278 a month all-in; NovoCare Pharmacy (Wegovy)↗ does not offer tirzepatide.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, IVIM Health is cheaper: $149 versus $349 a month all-in — a $200 monthly gap, $2,400 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

IVIM Health: the record, condensed

On tirzepatide, the number that matters at IVIM Health is $278 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Note the shape: $208 is the number in the marketing, $278 is the number at maintenance. The $70 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

A required $75/month membership is part of the deal, and part of the figure above: $203 of medication plus $75 of platform equals the $278 that leaves your account. Judge the membership by what it includes, but compare on the total.

Context for that figure: it ranks #3 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife↗, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.

IVIM Health’s semaglutide program bills $149 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

The all-in figure already contains a compulsory $75 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $74 would be exactly that kind of mirage.

To place the number: #3 of 20 verified programs, with the floor $16/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $200 a month. A year at this figure: $1,788 monthly-billed.

Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗

NovoCare Pharmacy (Wegovy): the record, condensed

On semaglutide, the number that matters at NovoCare Pharmacy (Wegovy) is $349 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

There is no membership line. $349 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #0 of 20 verified programs, with the floor $216/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth nothing a month — at which point brand deserves the first look. A year at this figure: $4,188 monthly-billed.

Operationally at NovoCare Pharmacy (Wegovy): shipping included (or retail via savings card); commitment none; cancellation no subscription; pharmacy named (Novo Nordisk direct / retail partners); states: 50 states; evidence source-verified, captured 2026-08-10. The full record with source and archive links: the NovoCare Pharmacy (Wegovy) page · visit NovoCare Pharmacy (Wegovy) ↗

Semaglutide: the duel in full

Put the two semaglutide figures side by side and hold them there: IVIM Health at $149, NovoCare Pharmacy (Wegovy) at $349 — a $200 monthly spread that compounds to $2,400 over a maintenance year and $4,800 over two.

Structure sharpens the gap: NovoCare Pharmacy (Wegovy)’s figure is dose-flat (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill the same), while IVIM Health’s is not — so NovoCare Pharmacy (Wegovy)’s number is a ceiling and IVIM Health’s advertised entry ($149) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

IVIM Health’s total includes a mandatory $75/month membership; NovoCare Pharmacy (Wegovy) has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Translate the $200/month spread into medication: $2,400 a year equals roughly 16.1 months of therapy at the cheaper program’s rate. That is the honest unit for gaps in this market — months of treatment, not abstract dollars — and it is why small-looking monthly differences decide long courses.

On best published rate — the lower of each program’s month-to-month price and its labeled 12-month-plan rate, which is the sort most price roundups quietly run — the duel reads: IVIM Health $149/mo month-to-month versus NovoCare Pharmacy (Wegovy) $349/mo month-to-month. Same winner on both bases — IVIM Health leads whether you compare month-to-month prices or committed-plan rates, which makes this one of the cleaner verdicts in the index. Prepaid rates are upfront commitments with refund terms to verify before they count.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: IVIM Health $447 monthly; NovoCare Pharmacy (Wegovy) $1,047 monthly — best path favors IVIM Health by $600. 6 months: IVIM Health $894 monthly; NovoCare Pharmacy (Wegovy) $2,094 monthly — best path favors IVIM Health by $1,200. 12 months: IVIM Health $1,788 monthly; NovoCare Pharmacy (Wegovy) $4,188 monthly — best path favors IVIM Health by $2,400. 24 months: IVIM Health $3,576 monthly; NovoCare Pharmacy (Wegovy) $8,376 monthly — best path favors IVIM Health by $4,800.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: IVIM Health publishes “not published”; NovoCare Pharmacy (Wegovy) publishes “50 states” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: NovoCare Pharmacy (Wegovy) names its network (Novo Nordisk direct / retail partners); IVIM Health does not, which shifts the burden of verification onto your intake questions.

Exit terms: IVIM Health — membership mandatory for duration; membership mandatory. NovoCare Pharmacy (Wegovy) — none; no subscription.

Evidence: IVIM Health source-verified (captured 2026-08-05); NovoCare Pharmacy (Wegovy) source-verified (2026-08-10).

A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.

§ If you move

Switching between IVIM Health and NovoCare Pharmacy (Wegovy)

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (IVIM Health: membership mandatory; NovoCare Pharmacy (Wegovy): no subscription) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings